litlas
Log inCreate account

James W. Murrough

Active 2006–2026

123
Papers
21,514
Citations
73
h-index
115
i10-index

Citations

Citations per year for James W. Murrough1993: 1 citations2000: 1 citations2003: 2 citations2007: 6 citations2008: 8 citations2009: 22 citations2010: 36 citations2011: 69 citations2012: 98 citations2013: 156 citations2014: 184 citations2015: 284 citations2016: 279 citations2017: 286 citations2018: 320 citations2019: 798 citations2020: 1,092 citations2021: 1,103 citations2022: 1,061 citations2023: 733 citations2024: 1,285 citations2025: 705 citations2026: 21 citations1994–1999: no citations, so these years are not shown2001–2002: no citations, so these years are not shown2004–2006: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,568 citing papers, 29.9% of this breakdownChina: 987 citing papers, 11.5% of this breakdownUnited Kingdom: 527 citing papers, 6.1% of this breakdownCanada: 522 citing papers, 6.1% of this breakdownGermany: 415 citing papers, 4.8% of this breakdownItaly: 296 citing papers, 3.5% of this breakdownAustralia: 287 citing papers, 3.3% of this breakdownJapan: 230 citing papers, 2.7% of this breakdownNetherlands: 223 citing papers, 2.6% of this breakdownSwitzerland: 175 citing papers, 2% of this breakdownSpain: 172 citing papers, 2% of this breakdownFrance: 166 citing papers, 1.9% of this breakdown
0%29.9%Other 23.6%

Institutions

Fields

  • Medicine40.3%
  • Neuroscience36.1%
  • Psychology13.3%
  • Biochemistry, Genetics and Molecular Biology6%
  • Health Professions1.4%
  • Immunology and Microbiology0.5%
  • Other2.4%

Topics

  • Tryptophan and brain disorders11.7%
  • Treatment of Major Depression11.2%
  • Stress Responses and Cortisol6.6%
  • Functional Brain Connectivity Studies4.2%
  • Neuroscience and Neuropharmacology Research3.5%
  • Neurotransmitter Receptor Influence on Behavior3.3%
  • Other59.5%

Coauthors

All papers

Open in search
  1. Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions

    Authors: Roger S. McIntyre, Mohammad Alsuwaidan, Bernhard T. Baune, Michael Berk, Koen Demyttenaere, Joseph F. Goldberg, Philip Gorwood, Roger Ho, Siegfried Kasper, Sidney H. Kennedy, Josefina T Ly-Uson, Rodrigo B. Mansur, R. Hamish McAllister‐Williams, James W. Murrough, Charles B. Nemeroff, Andrew A. Nierenberg, Joshua D. Rosenblat, Gerard Sanacora, Alan F. Schatzberg, Richard C. Shelton, Stephen M. Stahl, Madhukar H. Trivedi, Eduard Vieta, Maj Vinberg, Nolan Williams, Allan H. Young, Mario Maj - World Psychiatry 2023 cited by 690

  2. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation

    Authors: Roger S. McIntyre, Joshua D. Rosenblat, Charles B. Nemeroff, Gerard Sanacora, James W. Murrough, Michael Berk, Elisa Brietzke, Seetal Dodd, Philip Gorwood, Roger Ho, Dan V. Iosifescu, Carlos López‐Jaramillo, Siegfried Kasper, Kevin Kratiuk, Jung Goo Lee, Yena Lee, Leanna M.W. Lui, Rodrigo B. Mansur, George I. Papakostas, Mehala Subramaniapillai, Michael E. Thase, Eduard Vieta, Allan H. Young, Carlos A. Zarate, Stephen M. Stahl - American Journal of Psychiatry 2021 cited by 689

  3. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression

    Authors: Amit Anand, Sanjay J. Mathew, Gerard Sanacora, James W. Murrough, Fernando S. Goes, Murat Altinay, Amy Aloysi, Ali Abbas Asghar‐Ali, Brian S. Barnett, Lee C. Chang, Katherine A. Collins, Sara Costi, Sidra Iqbal, Manish K. Jha, Kamini Krishnan, Donald A. Malone, Sina Nikayin, Steven E. Nissen, Robert Ostroff, Irving M. Reti, Samuel T. Wilkinson, Kathy Wolski, Bo Hu - New England Journal of Medicine 2023 cited by 257

  4. Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

    Authors: James W. Murrough, Dan V. Iosifescu, Lee C. Chang, Rayan K. Al Jurdi, Charles E. Green, Andrew M. Perez, Syed Iqbal, Sarah Pillemer, Alexandra L. Foulkes, Asim A. Shah, Dennis S. Charney, Sanjay J. Mathew - American Journal of Psychiatry 2013 cited by 1,205

  5. Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

    Authors: Maurizio Fava, Marlene P. Freeman, Martina Flynn, Heidi Judge, Bettina B. Hoeppner, Cristina Cusin, Dawn F. Ionescu, Sanjay J. Mathew, Lee C. Chang, Dan V. Iosifescu, James W. Murrough, Charles DeBattista, Alan F. Schatzberg, Madhukar H. Trivedi, Manish K. Jha, Gerard Sanacora, Samuel T. Wilkinson, George I. Papakostas - Molecular Psychiatry 2018 cited by 437

  6. The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis

    Authors: Samuel T. Wilkinson, Elizabeth D. Ballard, Michael H. Bloch, Sanjay J. Mathew, James W. Murrough, Adriana Feder, P. Šóš, Gang Wang, Carlos A. Zarate, Gerard Sanacora - American Journal of Psychiatry 2017 cited by 677

  7. Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study

    Authors: Ahmed Tawakol, Amorina Ishai, Richard A. P. Takx, Amparo L. Figueroa, Abdelrahman Ali, Yannick Kaiser, Quynh A. Truong, Chloe JE Solomon, Claudia Calcagno, Venkatesh Mani, Cheuk Y. Tang, Willem J. M. Mulder, James W. Murrough, Udo Hoffmann, Matthias Nahrendorf, Lisa M. Shin, Zahi A. Fayad, Roger K. Pitman - The Lancet 2017 cited by 614

  8. Circulating myeloid-derived MMP8 in stress susceptibility and depression

    Authors: Flurin Cathomas, Hsiao‐Yun Lin, Kenny L. Chan, Long Li, Lyonna F. Parise, Johana Alvarez, Romain Durand-de Cuttoli, Antonio Aubry, Samer Muhareb, Fiona Desland, Yusuke Shimo, Aarthi Ramakrishnan, Molly Estill, Carmen Ferrer‐Pérez, Eric M. Parise, C. Matthias Wilk, Manuella P. Kaster, Jun Wang, Allison Sowa, William G.M. Janssen, Sara Costi, Adeeb Rahman, Nicolas Fernandez, Matthew Campbell, Filip K. Świrski, Eric J. Nestler, Li Shen, Miriam Mérad, James W. Murrough, Scott J. Russo - Nature 2024 cited by 153

  9. Screening and Management of Depression in Patients With Cardiovascular Disease

    Authors: Manish K. Jha, Arman Qamar, Muthiah Vaduganathan, Dennis S. Charney, James W. Murrough - Journal of the American College of Cardiology 2019 cited by 349

  10. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options

    Authors: Amir Garakani, James W. Murrough, Rafael C. Freire, Robyn P. Thom, Kaitlyn Larkin, Frank D. Buono, Dan V. Iosifescu - FOCUS The Journal of Lifelong Learning in Psychiatry 2020 cited by 412

  11. Neurobiology of resilience

    Authors: Scott J. Russo, James W. Murrough, Ming‐Hu Han, Dennis S. Charney, Eric J. Nestler - Nature Neuroscience 2012 cited by 1,187

  12. Targeting glutamate signalling in depression: progress and prospects

    Authors: James W. Murrough, Chadi G. Abdallah, Sanjay J. Mathew - Nature Reviews Drug Discovery 2017 cited by 479

  13. Neurobiology of Resilience: Interface Between Mind and Body

    Authors: Flurin Cathomas, James W. Murrough, Eric J. Nestler, Ming‐Hu Han, Scott J. Russo - Biological Psychiatry 2019 cited by 304

  14. A randomized proof-of-mechanism trial applying the ‘fast-fail’ approach to evaluating κ-opioid antagonism as a treatment for anhedonia

    Authors: Andrew D. Krystal, Diego A. Pizzagalli, Moria J. Smoski, Sanjay J. Mathew, John I. Nürnberger, Sarah H. Lisanby, Dan V. Iosifescu, James W. Murrough, Hongqiu Yang, Richard D. Weiner, Joseph R. Calabrese, Gerard Sanacora, Gretchen Hermes, Richard S.E. Keefe, Allen W. Song, Wayne K. Goodman, Steven T. Szabo, Alexis E. Whitton, Keming Gao, William Z. Potter - Nature Medicine 2020 cited by 229

  15. Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress

    Authors: Georgia E. Hodes, Madeline L. Pfau, Marylène Leboeuf, Sam A. Golden, Daniel J. Christoffel, Dana Bregman, Nicole Rebusi, Mitra Heshmati, Hossein Aleyasin, Brandon L. Warren, Benoît Labonté, Sarah R. Horn, Kyle Lapidus, Viktoria Stelzhammer, Erik H.F. Wong, Sabine Bahn, Vaishnav Krishnan, Carlos A. Bolaños‐Guzmán, James W. Murrough, Miriam Mérad, Scott J. Russo - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 706

  16. A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression

    Authors: Jaskaran Singh, Maggie Fedgchin, Ella Daly, Peter de Boer, Kimberly Cooper, Pilar Lim, Christine Pinter, James W. Murrough, Gerard Sanacora, Richard C. Shelton, Benji T. Kurian, Andrew Winokur, Maurizio Fava, Husseini K. Manji, Wayne C. Drevets, Luc Van Nueten - American Journal of Psychiatry 2016 cited by 529

  17. Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression

    Authors: James W. Murrough, Andrew M. Perez, Sarah Pillemer, Jessica Stern, Michael K. Parides, Marije aan het Rot, Katherine A. Collins, Sanjay J. Mathew, Dennis S. Charney, Dan V. Iosifescu - Biological Psychiatry 2012 cited by 785

  18. A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder

    Authors: Kyle Lapidus, Cara F. Levitch, Andrew M. Perez, Jess W. Brallier, Michael K. Parides, Laili Soleimani, Adriana Feder, Dan V. Iosifescu, Dennis S. Charney, James W. Murrough - Biological Psychiatry 2014 cited by 482

  19. Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder

    Authors: Adriana Feder, Michael K. Parides, James W. Murrough, Andrew M. Perez, Julia E. Morgan, Shireen Saxena, Katherine Kirkwood, Marije aan het Rot, Kyle Lapidus, Le-Ben Wan, Dan V. Iosifescu, Dennis S. Charney - JAMA Psychiatry 2014 cited by 616

  20. The role of the locus coeruleus in the generation of pathological anxiety

    Authors: Laurel Morris, Jordan G. McCall, Dennis S. Charney, James W. Murrough - Brain and Neuroscience Advances 2020 cited by 226

  21. A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder

    Authors: Adriana Feder, Sara Costi, Sarah Rutter, Abigail B. Collins, Usha Govindarajulu, Manish K. Jha, Sarah R. Horn, Marin Kautz, Morgan Corniquel, Katherine A. Collins, Laura Bevilacqua, Andrew Glasgow, Jess W. Brallier, Robert H. Pietrzak, James W. Murrough, Dennis S. Charney - American Journal of Psychiatry 2021 cited by 237

  22. Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression

    Authors: Marije aan het Rot, Katherine A. Collins, James W. Murrough, Andrew M. Perez, David L. Reich, Dennis S. Charney, Sanjay J. Mathew - Biological Psychiatry 2009 cited by 690

  23. International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators

    Authors: Rebecca B. Price, Nicholas Kissel, Andrew Baumeister, Rebecca Rohac, Mary L. Woody, Elizabeth D. Ballard, Carlos A. Zarate, J.F.W. Deakin, Chadi G. Abdallah, Adriana Feder, Dennis S. Charney, Michael F. Grunebaum, J. John Mann, Sanjay J. Mathew, Bronagh Gallagher, Declan M. McLoughlin, James W. Murrough, Suresh Muthukumaraswamy, Rebecca McMillan, Rachael L. Sumner, George I. Papakostas, Maurizio Fava, Rebecca S. Hock, Jennifer L. Phillips, Pierre Blier, Paulo Shiroma, P. Šóš, Tung‐Ping Su, Mu‐Hong Chen, Mikael Tiger, Johan Lundberg, Samuel T. Wilkinson, Meredith L. Wallace - Molecular Psychiatry 2022 cited by 79

  24. Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials

    Authors: Katrina Witt, Jennifer Potts, Anna A.M. Hubers, Michael F. Grunebaum, James W. Murrough, Colleen Loo, Andrea Cipriani, Keith Hawton - Australian & New Zealand Journal of Psychiatry 2019 cited by 203